Compounds > bismuth
Page last updated: 2024-08-26

bismuth and Acute Myelogenous Leukemia

bismuth has been researched along with Acute Myelogenous Leukemia in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (10.00)18.2507
2000's4 (40.00)29.6817
2010's5 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jurcic, JG3
Friesen, C; Hormann, I; Leib, O; Marx, S; Miltner, E; Moreno, J; Roscher, M1
Jurcic, JG; Rosenblat, TL1
Chanel, S; Divgi, CR; Heaney, ML; Jurcic, JG; Larson, SM; McDevitt, MR; Morgenstern, A; Mulford, DA; Panageas, KS; Pandit-Taskar, N; Rosenblat, TL; Scheinberg, DA; Sgouros, G1
Appelbaum, FR; Axtman, A; Bäck, T; Fisher, DR; Frayo, S; Gopal, AK; Green, DJ; Hamlin, DK; Kenoyer, AL; Lin, Y; Orgun, N; Orozco, J; Pagel, JM; Park, SI; Press, OW; Shenoi, J; Wilbur, DS1
Ballangrud, AM; Brechbiel, MW; Divgi, CR; Finn, RD; Hamacher, KA; Humm, JL; Jurcic, JG; Larson, SM; Ma, D; McDevitt, MR; Molinet, R; Scheinberg, DA; Sgouros, G1
Featherstone, C1
Finn, RD; Ma, D; McDevitt, MR; Scheinberg, DA1

Reviews

4 review(s) available for bismuth and Acute Myelogenous Leukemia

ArticleYear
Clinical Studies with Bismuth-213 and Actinium-225 for Hematologic Malignancies.
    Current radiopharmaceuticals, 2018, Volume: 11, Issue:3

    Topics: Actinium; Alpha Particles; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Bismuth; Clinical Trials as Topic; Humans; Leukemia, Myeloid, Acute; Radiochemistry; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals

2018
Targeted alpha-particle immunotherapy for acute myeloid leukemia.
    American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, 2014

    Topics: Alpha Particles; Animals; Antibodies, Monoclonal, Humanized; Bismuth; Clinical Trials as Topic; Humans; Immunoconjugates; Leukemia, Myeloid, Acute; Molecular Targeted Therapy; Radioimmunotherapy; Radioisotopes

2014
Immunotherapy for acute myeloid leukemia.
    Current oncology reports, 2005, Volume: 7, Issue:5

    Topics: Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Bismuth; Cell Adhesion Molecules; Gemtuzumab; Humans; Immunotherapy; Immunotoxins; Leukemia, Myeloid, Acute; Leukocyte Common Antigens; Radioimmunotherapy; Radioisotopes; Recurrence; Remission Induction; Sialic Acid Binding Ig-like Lectin 3; T-Lymphocytes

2005
Antibody therapy of acute myelogenous leukemia.
    Cancer biotherapy & radiopharmaceuticals, 2000, Volume: 15, Issue:4

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bismuth; Clinical Trials as Topic; Gemtuzumab; Humans; Immunization, Passive; Immunoconjugates; Leukemia, Myeloid, Acute; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals

2000

Trials

2 trial(s) available for bismuth and Acute Myelogenous Leukemia

ArticleYear
Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, Nov-01, Volume: 16, Issue:21

    Topics: Adult; Aged; Aged, 80 and over; Alpha Particles; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Bismuth; Cytarabine; Drug Administration Schedule; Female; Humans; Immunoconjugates; Leukemia, Myeloid, Acute; Male; Middle Aged; Radioimmunotherapy; Radioisotopes; Remission Induction

2010
Targeted alpha particle immunotherapy for myeloid leukemia.
    Blood, 2002, Aug-15, Volume: 100, Issue:4

    Topics: Alpha Particles; Antibodies, Monoclonal; Antigens, CD34; Bismuth; Blast Crisis; Humans; Immunotoxins; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Leukopenia; Radioisotopes

2002

Other Studies

4 other study(ies) available for bismuth and Acute Myelogenous Leukemia

ArticleYear
Anti-CD33-antibodies labelled with the alpha-emitter Bismuth-213 kill CD33-positive acute myeloid leukaemia cells specifically by activation of caspases and break radio- and chemoresistance by inhibition of the anti-apoptotic proteins X-linked inhibitor o
    European journal of cancer (Oxford, England : 1990), 2013, Volume: 49, Issue:11

    Topics: Antibodies, Monoclonal; Apoptosis; bcl-X Protein; Bismuth; Caspases; Cell Line, Tumor; Drug Resistance, Neoplasm; HL-60 Cells; Humans; Immunoconjugates; Leukemia, Myeloid, Acute; Lymphoma, B-Cell; Radioimmunotherapy; Radioisotopes; Sialic Acid Binding Ig-like Lectin 3; X-Linked Inhibitor of Apoptosis Protein

2013
Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft model.
    Blood, 2011, Jul-21, Volume: 118, Issue:3

    Topics: Animals; Antibodies; Biotin; Bismuth; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Immunologic; Dose-Response Relationship, Radiation; Female; Humans; Leukemia, Myeloid, Acute; Leukocyte Common Antigens; Mice; Mice, Inbred BALB C; Organometallic Compounds; Radioimmunotherapy; Radioisotopes; Remission Induction; Streptavidin; Survival Rate; Xenograft Model Antitumor Assays

2011
Alpha-particle-emitting radioisotopes coupled to antibody for acute myeloid leukaemia treatment.
    Molecular medicine today, 1997, Volume: 3, Issue:6

    Topics: Actinium; Alpha Particles; Bismuth; Humans; Leukemia, Myeloid, Acute; Radioimmunotherapy; Radioisotopes

1997
Rapid preparation of short-lived alpha particle emitting radioimmunopharmaceuticals.
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2001, Volume: 55, Issue:4

    Topics: Alpha Particles; Antibodies, Monoclonal; Bismuth; Chromatography, Ion Exchange; Clinical Trials as Topic; Half-Life; Humans; Immunoconjugates; Leukemia, Myeloid, Acute; Radioisotopes; Radiopharmaceuticals

2001